Relevant for
FixVUE, InSituPlex, U-VUE
Description Overview highlighting the use of the InSituPlex® (ISP) a novel, robust mIF assay technology reliant on conjugating DNA barcodes to antibodies and using sequence-specific DNA-DNA hybridization tolabel antibodies for spatial profiling of immuno-oncology targets in FFPE tumor tissue
Presented at: AACR 2021
Relevant for
Collaboration, FixVUE, InSituPlex
Description The tumor microenvironment (TME) represents a complex interaction of immune and host cellsand can be described broadly as ‘inflamed’, ‘immune excluded’ and ‘desert’; categories that mayserve as predictive parameters for response to different immunotherapies. Multiplexedfluorescence and associated digital imaging platforms are important tools for defining the spatialcomponents of the TME and can accelerate development of novel immunotherapy strategies.
Marie Cumberbatch, Douglas Wood, Christopher Womack, Milan Bhagat, Angela Vasaturo, Mael Manesse and Lorcan Sherry (TriStar, OracleBio)
Presented at: AACR 2020
Relevant for
Collaboration, FixVUE, InSituPlex
Presented at: AACR 2021
Relevant for
Collaboration, FixVUE, InSituPlex
Description The tumor microenvironment (TME) represents a complex interaction of immune and host cellsand can be described broadly as ‘inflamed’, ‘immune excluded’ and ‘desert’; categories that mayserve as predictive parameters for response to different immunotherapies. Multiplexedfluorescence and associated digital imaging platforms are important tools for defining the spatialcomponents of the TME and can accelerate development of novel immunotherapy strategies.
Presented at: AACR 2021
Relevant for
Collaboration, FixVUE, InSituPlex
Description The tumor microenvironment (TME) represents a complex interaction of immune and host cellsand can be described broadly as ‘inflamed’, ‘immune excluded’ and ‘desert’; categories that mayserve as predictive parameters for response to different immunotherapies. Multiplexedfluorescence and associated digital imaging platforms are important tools for defining the spatialcomponents of the TME and can accelerate development of novel immunotherapy strategies.
Presented at: AACR 2021
Relevant for
Collaboration, FixVUE, InSituPlex
Description The tumor microenvironment (TME) represents a complex interaction of immune and host cellsand can be described broadly as ‘inflamed’, ‘immune excluded’ and ‘desert’; categories that mayserve as predictive parameters for response to different immunotherapies. Multiplexedfluorescence and associated digital imaging platforms are important tools for defining the spatialcomponents of the TME and can accelerate development of novel immunotherapy strategies.
Presented at: AACR 2021
Relevant for
Collaboration, InSituPlex
Description The tumor microenvironment (TME) represents a complex interaction of immune and host cellsand can be described broadly as ‘inflamed’, ‘immune excluded’ and ‘desert’; categories that mayserve as predictive parameters for response to different immunotherapies. Multiplexedfluorescence and associated digital imaging platforms are important tools for defining the spatialcomponents of the TME and can accelerate development of novel immunotherapy strategies.
Relevant for
Collaboration, FixVUE, InSituPlex
Description Overview highlighting the use of the InSituPlex® (ISP) a novel, robust mIF assay technology reliant on conjugating DNA barcodes to antibodies and using sequence-specific DNA-DNA hybridization tolabel antibodies for spatial profiling of immuno-oncology targets in FFPE tumor tissue
Anne Hellebust, Kyla Teplitz, Katir K Patel, Karan Sharma, Amanda Bares, Mael Manesse, Mark Burton, Bonnie Phillips, Sean Downing and Kate Lillard
Presented at: AACR 2021
Relevant for
Collaboration, FixVUE, InSituPlex
Description The tumor microenvironment (TME) represents a complex interaction of immune and host cellsand can be described broadly as ‘inflamed’, ‘immune excluded’ and ‘desert’; categories that mayserve as predictive parameters for response to different immunotherapies. Multiplexedfluorescence and associated digital imaging platforms are important tools for defining the spatialcomponents of the TME and can accelerate development of novel immunotherapy strategies.
Presented at: AACR 2021
Relevant for
FixVUE, InSituPlex
Description The tumor microenvironment (TME) represents a complex interaction of immune and host cellsand can be described broadly as ‘inflamed’, ‘immune excluded’ and ‘desert’; categories that mayserve as predictive parameters for response to different immunotherapies. Multiplexedfluorescence and associated digital imaging platforms are important tools for defining the spatialcomponents of the TME and can accelerate development of novel immunotherapy strategies.
Marie Cumberbatch, Douglas Wood, Christopher Womack, Milan Bhagat, Angela Vasaturo, Mael Manesse and Lorcan Sherry (TriStar, OracleBio)
Presented at: AACR 2021
Relevant for
Collaboration, FixVUE, InSituPlex
Description The tumor microenvironment (TME) represents a complex interaction of immune and host cellsand can be described broadly as ‘inflamed’, ‘immune excluded’ and ‘desert’; categories that mayserve as predictive parameters for response to different immunotherapies. Multiplexedfluorescence and associated digital imaging platforms are important tools for defining the spatialcomponents of the TME and can accelerate development of novel immunotherapy strategies.
Relevant for
Collaboration, FixVUE, InSituPlex
Description Overview highlighting the use of the InSituPlex® (ISP) a novel, robust mIF assay technology reliant on conjugating DNA barcodes to antibodies and using sequence-specific DNA-DNA hybridization tolabel antibodies for spatial profiling of immuno-oncology targets in FFPE tumor tissue
